The primary aim of the disease management program (DMP) for patients with asthma is to improve health outcomes and to reduce costs. Five years after its introduction in Germany, no consensus has yet been reached as to whether DMP has been effective in reaching these goals.
OBJECTIVE:
To evaluate the DMP for asthma in Bavaria using routinely collected subject medical records.
METHODS:
A longitudinal population-based study encompassing over 100,000 DMP participants between 2006 (when the program began) and 2010.
RESULTS:
The prescription rate of oral corticosteroids dropped from 15.7% in 2006 to 13.6% in 2007, and again from 7.5% in 2008 to 5.9% in 2010 (P < .001). The proportion of subjects with asthma self-management education increased from 4.4% to 23.4% (P < .001). Utilization of an individual asthma action plan increased from 40.3% to 69.3% (P < .001). Hospitalization decreased from 2.8% to 0.7% (P < .001).
CONCLUSIONS:
In the first 4 years of DMP there was an improvement in pharmacotherapy and patient self management. The proportion of subjects requiring hospitalization decreased. Our results suggest that the German DMP for asthma has been effective in enhancing the quality of care in regard to an improved symptom frequency, adherence to guidelines, pharmacotherapy, and hospitalization.
van LenteEJ. Erfahrungen mit strukturierten Behandlungsprogrammen (DMPs) in Deutschland, Versorgungs-Report 2011: Schwerpunkt: Chronische Erkrankungen. Schattauer Berlin, 2010; 55-82. Article in German.
2.
StockS, DrabikA, BüscherG, GrafC, UllrichW, GerberA, et al. German Diabetes Management Programs improve quality and curb coasts, Health Aff (Millwood), 2010; 29(12):2197-2205.
3.
MikschA, LauxG, OseD, JoosS, CampbellS, RiensB, et al. Is there a survival benefit within a German primary care-based disease management program?. Am J Manag Care, 2010; 16(1):49-54.
4.
StarkRG, SchunkMV, MeisingerC, RathmannW, LeidlR, HolleR, et al. Medical care of type 2 diabetes in German disease management programs: a population-based evaluation. Diabetes Metab Res Rev, 2011; 27(4):383-391.
WindtR, GlaeskeG. Effects of a German asthma disease management program using sickness fund claims data. J Asthma, 2010; 47(6):674-679.
7.
MaciejewskiML, ChenS, AuDH. Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care, 2009; 54(7):878-886.
8.
MattkeS, SeidM, MaS. Evidence for the effect of disease management: is $1 billion a year a good investment?. Am J Manag Care, 2007; 13(12):670-676.
9.
SteutenL, VrijhoefB, Van MerodeF, WesselingGJ, SpreeuwenbergC. Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. Int J Qual Health Care, 2006; 18(6):429-436.
10.
GibsonPG, PowellH, CoughlanJ, WilsonAJ, AbramsonM, HaywoodP, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev, 2003;(1):CD001117.
11.
CastroM, ZimmermannNA, CrockerS, BradleyJ, LevenC, SchechtmanKB, et al. Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med, 2003; 168(9):1095-1099.
CochranWG. Some methods for strengthening the common chi square tests. Biometrics, 1954;(10):417-451.
17.
ArmitageP. Tests for linear trends in proportions and frequencies. Biometrics, 1955;(11):375-386.
18.
BatesD, ChambersJ, DalgaardP, FalconS, GentlemanR, HornikK, et al; The R Core Development Team. R: a language and environment for statistical computing. http://www.r-project.org. Accessed April 18, 2013.
19.
GabadinhoA, RitschardG, MüllerNS, StuderM. Analyzing and visualizing state sequences in R with TraMineR. J Statistic Softw, 2011;(40):1-37.
20.
LemmensKMM, NieboerAP, HuijsmanR. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med, 2009; 103(5):670-691.
ArmourC, Bosnic-AnticevichS, BrillantM, BurtonD, EmmertonL, KrassI, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax, 2007; 62(6):496-592.
23.
SchneiderA, WensingM, BiesseckerK, QuinzlerR, Kaufmann-KolleP, SzecsenyiJ. Impact of quality circles for improvement of asthma care: results of a randomized controlled trial. J Eval Clin Pract, 2008; 14(2):185-190.
24.
OxmanAD, ThomsonMA, DavisDA, HaynesRB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ, 1995; 153(10):1423-1431.
25.
GrolR, GrimshawJ. From best evidence to best practice: effective implementation of change in patients' care. Lancet, 2003; 362(9391):1225-1230.
26.
DelarondeS, PeruccioDL, BauerBJ. Improving asthma treatment in a managed care population. Am J Manag Care, 2005; 11(6):361-368.
27.
SuhDC, ShinSK, OkparaI, VoytovichRM, ZimmermanA, et al. Impact of a targeted asthma intervention program on treatment costs in patients with asthma. Am J Manag Care, 2001; 7(9):897-906.
28.
LugtenbergM, BurgersJS, WestertGP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care, 2009; 18(5):385-392.
29.
RabeKF, VermeirePA, SorianoJB, MaierWC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J, 2000; 16(5):802-807.
30.
LangenU, KnopfH, MelchertH. [Drug therapy of asthma. Results of the 1998 German National Health Interview and Examination Study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2006; 49(9):903-910. Article in German.
31.
JohnsonA, BergG, FleeglerE, SauerbrunM. A matched-cohort study of selected clinical and utilization outcomes for an asthma care support program. Dis Manag, 2005; 8(3):144-154.
32.
WegscheiderK. DMP: Methodik für faire Vergleiche. Monitor Versorgungsforschung, 2011; 4(1):25-27.
